MEX3A and Patent ductus arteriosus: According to the Immunohistochemical (IHC) staining (Fig. 1a and Table 1), the expression of MEX3A in PDA tissues was significantly higher than that in normal tissues (P <0.001), which allowed the subsequent correlation analysis between MEX3A expression and clinicopathological data.